UPCOMING EVENTS
BioFIT 2021
Digital
BioFIT 2021
From to
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming from public research institutions, academic spin-offs and emerging biotech companies. Together with big pharma, biotech and diagnostic companies, BioFIT operates as a platform to build partnerships for all public and private actors. BioFIT is also the European marketplace for pre-seed, seed and Series A investment in Life Sciences.
CPhI China 2021
Shanghai New Int'l Expo Centre (SNIEC)
E1D12
CPhI China 2021
From to
Each year CPhI unites more than 100,000 pharmaceutical professionals through exhibitions, conferences and online communities to network, identify business opportunities and expand the global market. This year, our team from Shanghai will represent CARBOGEN AMCIS and Dishman Carbogen Amcis Ltd. at the CPhI China 2021. Get in contact with us and let’s meet in Shanghai!
Zurich Life Science Day 2022
Digital
Zurich Life Science Day 2022
The largest life science career day in Switzerland. From to
If you are a life scientist, student, or postgraduate, looking for opportunities or just curious and interested in exploring new career paths, then the Zurich Life Science Day is the right event for you! Don't miss your chance to talk to company representatives and to discover the different aspects of the industry through interesting talks and informal meetings. Connect and broaden your network on February 8th, 2022 at the 13th edition of Zurich Life Science Day!
Life Science Zurich Young Scientist Network is a non-profit organization created and run by a group of graduate students & post-docs of the University of Zurich and the ETH Zurich.
ChemSpec Europe 2022
Messe Frankfurt
CS-G80, Hall 12.1
ChemSpec Europe 2022
From to
COVID-19, sustainability, new trends, and digitalisation are not just buzzwords. In fact, these aspects and the ongoing demand for innovations determine the industry.
The choice of the right suppliers and the exchange of knowledge within international industry networks is more important than ever. With a highly specialised exhibition profile, Chemspec Europe 2022 is a key event for buyers, traders and agents in search of bespoke solutions and innovative substances.
The 36th International Exhibition for Fine and Speciality Chemicals will take place from 31 May - 01 June 2022 at Messe Frankfurt, Germany.
LATEST NEWS
NH TherAguix announces the release of a new clinical batch for its drug AGuIX, manufactured by CARBOGEN AMCIS
MEYLAN, France, BUBENDORF, Switzerland, (November 3rd, 2021) - NH TherAguix, a clinical stage company developing innovative nanomedicine for the treatment of cancer, and CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and Drug Products manufacturing company, announced today the release of a new batch of AGuIX Drug Product for clinical trials.
CARBOGEN AMCIS announces successful FDA inspection of its facility in Aarau, Switzerland
BUBENDORF, Switzerland (27 October 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) manufacturing company, announces the completion of a U.S. Food and Drug Administration (FDA) inspection at the site in Aarau, Switzerland.
CARBOGEN AMCIS announces a co-investment agreement of more than CHF 4 million with a long-standing Europe-based client
BUBENDORF, Switzerland (27 Aug 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today the signing of a co-investment agreement with one of its key European customers.
CARBOGEN AMCIS acquires new property at Bubendorf site
BUBENDORF, Switzerland (24 June, 2021) Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced the acquisition of a new property in Bubendorf.
CARBOGEN AMCIS announces a co-investment agreement of more than CHF 15 million with a key client to expand Swiss site
BUBENDORF, Switzerland (April 29th, 2021) — Switzerland-based CARBOGEN AMCIS, a pharmaceutical process development and Active Pharmaceutical Ingredient (API) and drug products manufacturing company, announced today a joint funding agreement with a long standing Japan based customer to build a site extension at the Bubendorf site in Switzerland.
Dishman Carbogen Amcis Ltd announces successful results from the partnership with Boston University School of Medicine on study that uncovers treatment for vitamin D deficiency (2)
Ahmedabad, India (May 21th, 2021) — India-based Dishman Carbogen Amcis Limited, a global outsourcing partner for the pharmaceutical industry, welcomes the results of a new study that provides critical insights into the treatment of vitamin D deficiency in obesity and in fat malabsorption syndromes. The research was conducted by Boston University School of Medicine and supported in part by a grant from Dishman Carbogen Amcis Ltd’s wholly owned subsidiary CARBOGEN AMCIS B.V.
For more information
download our Company Profile
brochure or contact us today.
